194 related articles for article (PubMed ID: 24183915)
1. BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.
Döring G; Bragonzi A; Paroni M; Aktürk FF; Cigana C; Schmidt A; Gilpin D; Heyder S; Born T; Smaczny C; Kohlhäufl M; Wagner TO; Loebinger MR; Bilton D; Tunney MM; Elborn JS; Pier GB; Konstan MW; Ulrich M
J Cyst Fibros; 2014 Mar; 13(2):156-63. PubMed ID: 24183915
[TBL] [Abstract][Full Text] [Related]
2. A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Konstan MW; Döring G; Heltshe SL; Lands LC; Hilliard KA; Koker P; Bhattacharya S; Staab A; Hamilton A;
J Cyst Fibros; 2014 Mar; 13(2):148-55. PubMed ID: 24440167
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
Stotland PK; Radzioch D; Stevenson MM
Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Birke FW; Meade CJ; Anderskewitz R; Speck GA; Jennewein HM
J Pharmacol Exp Ther; 2001 Apr; 297(1):458-66. PubMed ID: 11259574
[TBL] [Abstract][Full Text] [Related]
6. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
7. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD; Gibson RL; Emerson J; McNamara S; Burns JL; Wagener JS; Ramsey BW; ;
J Pediatr; 2009 Feb; 154(2):183-8. PubMed ID: 18822427
[TBL] [Abstract][Full Text] [Related]
8. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.
Wang Y; Cela E; Gagnon S; Sweezey NB
Respir Res; 2010 Nov; 11(1):166. PubMed ID: 21118573
[TBL] [Abstract][Full Text] [Related]
9. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
10. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Schmitt-Grohé S; Zielen S
Paediatr Drugs; 2005; 7(6):353-63. PubMed ID: 16356023
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.
Young RL; Malcolm KC; Kret JE; Caceres SM; Poch KR; Nichols DP; Taylor-Cousar JL; Saavedra MT; Randell SH; Vasil ML; Burns JL; Moskowitz SM; Nick JA
PLoS One; 2011; 6(9):e23637. PubMed ID: 21909403
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique.
Guilbault C; Martin P; Houle D; Boghdady ML; Guiot MC; Marion D; Radzioch D
Lab Anim; 2005 Jul; 39(3):336-52. PubMed ID: 16004694
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine.
Becker KA; Li X; Seitz A; Steinmann J; Koch A; Schuchman E; Kamler M; Edwards MJ; Caldwell CC; Gulbins E
Cell Physiol Biochem; 2017; 43(4):1603-1616. PubMed ID: 29040968
[TBL] [Abstract][Full Text] [Related]
15. KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa.
Jain R; Beckett VV; Konstan MW; Accurso FJ; Burns JL; Mayer-Hamblett N; Milla C; VanDevanter DR; Chmiel JF;
J Cyst Fibros; 2018 Jul; 17(4):484-491. PubMed ID: 29292092
[TBL] [Abstract][Full Text] [Related]
16. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.
Martin C; Ohayon D; Alkan M; Mocek J; Pederzoli-Ribeil M; Candalh C; Thevenot G; Millet A; Tamassia N; Cassatella MA; Thieblemont N; Burgel PR; Witko-Sarsat V
Am J Respir Cell Mol Biol; 2016 May; 54(5):740-50. PubMed ID: 26517580
[TBL] [Abstract][Full Text] [Related]
19. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
Malhotra S; Hayes D; Wozniak DJ
J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
